Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Locally Advanced Rectal Cancer × toripalimab × Clear all

Phase

Status

Recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 5 Carcinoma, Hepatocellular 4 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Nasopharyngeal Carcinoma 2 Advanced Lung Cancer 2 Triple Negative Breast Neoplasms 1 Treatment-naive Advanced Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced Rectal Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Kidney Neoplasms 1 High-Risk Resectable NSCLC 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Chondrosarcoma 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Anus Neoplasms 1 Anal Canal Carcinoma 1 Advanced Solid Tumors 1 Advanced Malignant Tumors 1

Interventions

Capecitabine 3 spartalizumab 2 Radiation 2 veliparib 1 toripalimab 1 tislelizumab 1 sintilimab 1 peposertib 1 XELOX 1 Radiotherapy 1 Oxaliplatin 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04518280 2025-01-17

TORCH

Fudan University

Phase 2 Completed

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡